ONLINE DATABASE SEARCH - OI-LS-313-MEMO
1. 44662 OI-LS-313; PUBMED-OI-1/11/2004
Clinical utility of antifungal pharmacokinetics and pharmacodynamics
Andes, D
Curr Opin Infect Dis 2004. 17(6): 533-40
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15640707&dopt=abstract
2. 44663 OI-LS-313; PUBMED-OI-1/11/2004
Antitubercular activity of triterpenoids from asteraceae flowers
Akihisa, T, Franzblau, SG, Ukiya, M, Okuda, H, Zhang, F, Yasukawa, K, Suzuki, T, and Kimura, Y
Biol Pharm Bull 2005. 28(1): 158-60
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15635183&dopt=abstract
3. 44664 OI-LS-313; PUBMED-OI-1/11/2004
IFN-{alpha}{beta} Secreted during Infection Is Necessary but Not Sufficient for Negative Feedback Regulation of IFN-{alpha}{beta} Signaling by Mycobacterium tuberculosis
Prabhakar, S, Qiao, Y, Canova, A, Tse, DB, and Pine, R
J Immunol 2005. 174(2): 1003-1012
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15634924&dopt=abstract
4. 44665 OI-LS-313; PUBMED-OI-1/11/2004
Evaluation of Mycograb(R), amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies
Nooney, L, Matthews, RC, and Burnie, JP
Diagn Microbiol Infect Dis 2005. 51(1): 19-29
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15629225&dopt=abstract
5. 44666 OI-LS-313; PUBMED-OI-1/11/2004
The Crystal Structure of Mycobacterium tuberculosis Thymidylate Kinase in Complex with 3'-Azidodeoxythymidine Monophosphate Suggests a Mechanism for Competitive Inhibition(,)
Fioravanti, E, Adam, V, Munier-Lehmann, H, and Bourgeois, D
Biochemistry 2005. 44(1): 130-137
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15628853&dopt=abstract
6. 44667 OI-LS-313; SCIFINDER-OI-1/5/2005
Phosphatidylinositol 3-Kinase and Frabin Mediate Cryptosporidium parvum Cellular Invasion via Activation of Cdc42
Chen, Xian-Ming, Splinter, Patrick L, Tietz, Pamela S, Huang, Bing Q, Billadeau, Daniel D, and LaRusso, Nicholas F
Journal of Biological Chemistry 2004. 279(30): 31671-31678
7. 44668 OI-LS-313; PUBMED-OI-1/11/2004
Further Acquisition of Drug-Resistance in Multidrug-Resistant Tuberculosis during Chemotherapy
Toyota, E, Sekiguchi, J, Shimizu, H, Fujino, T, Otsuka, Y, Yoshikura, H, Kuratsuji, T, Kirikae, T, and Kudo, K
Jpn J Infect Dis 2004. 57(6): 292-4
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15623961&dopt=abstract
8. 44669 OI-LS-313; PUBMED-OI-1/11/2004
Antimycobacterial Compounds from Piper sanctum
Mata, R, Morales, I, Perez, O, Rivero-Cruz, I, Acevedo, L, Enriquez-Mendoza, I, Bye, R, Franzblau, S, and Timmermann, B
J Nat Prod 2004. 67(12): 1961-1968
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15620234&dopt=abstract
9. 44670 OI-LS-313; SCIFINDER-OI-1/5/2005
In vitro activity on Cryptosporidium parvum oocyst of different drugs with recognized anticryptosporidial efficacy
Castro-Hermida, JA, Pors, I, Ares-Mazas, E, and Chartier, C
Revue de Medecine Veterinaire (Toulouse, France) 2004. 155(8-9): 453-456
10. 44671 OI-LS-313; SCIFINDER-OI-1/5/2005
In Vitro Antibacterial and Antifungal Activities of Extracts and Compounds from Uvaria scheffleri
Moshi, Mainen, Joseph, Cosam, Innocent, Esther, and Nkunya, Mayunga
Pharmaceutical Biology (Lisse, Netherlands) 2004. 42(4-5): 269-273
11. 44672 OI-LS-313; SCIFINDER-OI-1/5/2005
Synthesis and potent antimicrobial activity of some novel 4-(5,6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides
Oezden, Seckin, Karatas, Hacer, Yildiz, Sulhiye, and Goeker, Hakan
Archiv der Pharmazie (Weinheim, Germany) 2004. 337(10): 556-562
12. 44673 OI-LS-313; PUBMED-OI-1/11/2004
The past, present and future of antiviral drug discovery
Littler, E
IDrugs 2004. 7(12): 1104-12
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15599804&dopt=abstract
13. 44674 OI-LS-313; SCIFINDER-OI-1/5/2005
Synthesis and microbiological activity of some substituted N-(2-hydroxy-4-nitrophenyl)benzamides and phenylacetamides as possible metabolites of antimicrobial active benzoxazoles
Oeren, Ilkay Yildiz, Aki-Sener, Esin, Ertas, Cengiz, Arpaci, Oezlem Temiz, Yalcin, Ismail, and Altanlar, Nurten
Turkish Journal of Chemistry 2004. 28(4): 441-449
14. 44675 OI-LS-313; PUBMED-OI-1/11/2004
Inhibitors of virus replication: recent developments and prospects
Magden, J, Kaariainen, L, and Ahola, T
Appl Microbiol Biotechnol 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15592828&dopt=abstract
15. 44676 OI-LS-313; SCIFINDER-OI-1/5/2005
Synthesis and antifungal activity of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(4-substituted acyl piperazin-1-yl)-2-propanols
Liang, Shuang, Liu, Chao-mei, Zhu, Jie, He, Qiu-qin, Jiang, Yuan-ying, and Cao, Yong-bing
Journal of Medical Colleges of PLA 2004. 19(3): 142-145
16. 44677 OI-LS-313; SCIFINDER-OI-1/5/2005
Isatin-derived Antibacterial and Antifungal Compounds and their Transition Metal Complexes
Chohan, Zahid H, Pervez, Humayun, Rauf, A, Khan, Khalid M, and Supuran, Claudiu T
Journal of Enzyme Inhibition and Medicinal Chemistry 2004. 19(5): 417-423
17. 44678 OI-LS-313; SCIFINDER-OI-1/5/2005
In vitro anti-candidal activity of the essential oil of Illicium verum
Zhao, Junli, Luo, Zhicheng, Wu, Sanmao, Zhou, Xiaoli, Xue, Xiaoyun, Shi, Lei, and Li, Wenzhu
Zhonghua Pifuke Zazhi 2004. 37(8): 475-477
18. 44679 OI-LS-313; SCIFINDER-OI-1/5/2005
Synthesis and antifungal activity of cholesterol-hydrazone derivatives
Loncle, Celine, Brunel, Jean Michel, Vidal, Nicolas, Dherbomez, Michel, and Letourneux, Yves
European Journal of Medicinal Chemistry 2004. 39(12): 1067-1071
19. 44680 OI-LS-313; SCIFINDER-OI-1/5/2005
Preparation of 3-deoxyanthocyanidine compounds and their use as antimicrobial agents
George, Florian and Fellague, Toufik
PATENT: FR 2855172 ISSUE DATE: 20041126
APPLICATION: 2003-6088 PP: 60 pp.
ASSIGNEE: (Synth'e 163, Fr.
20. 44681 OI-LS-313; WOS-OI-1/2/2005
Albuferon (TM) - A novel therapeutic agent for hepatitis C: Results of a phase 1/2 study in treatment experienced subjects with chronic hepatitis C
Balan, V, Sulkowski, M, Nelson, D, Everson, G, Lambiase, L, Post, A, Redfield, R, Wiesner, R, Davis, G, Neumann, A, Recta, J, Moore, P, Osborn, B, Novello, L, Freimuth, W, and Subramanian, M
HEPATOLOGY 2004. 40(4): 280A-281A, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100267
21. 44682 OI-LS-313; SCIFINDER-OI-1/5/2005
Diastereoselective Synthesis and Antifungal Activity of Glycosyl Isoxazolines
Mishra, Ram Chandra, Tewari, Neetu, Verma, Shyam Sunder, Tripathi, Rama Pati, Kumar, Manish, and Shukla, Praveen Kumar
Journal of Carbohydrate Chemistry 2004. 23(6 & 7): 353-374
22. 44683 OI-LS-313; WOS-OI-1/2/2005
Final results of ANRS HC02-RIBAVIC: A randomized controlled trial of pegylated-interferon alfa-2B plus ribavirin vs interferon alfa-2B plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-infected
Pol, S, Carrat, F, Bani-Sadr, F, Rosenthal, E, Lunel, F, Morand, P, Salmon, D, Pialoux, G, Patrice, C, and Christian, P
HEPATOLOGY 2004. 40(4): 315A-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100353
23. 44684 OI-LS-313; WOS-OI-1/2/2005
Dynamics of HCV free-virion and immunecomplex during interferon therapy with and without ribavirin in genotype-1B chronic hepatitis C
Fujita, N, Kaito, M, Takeo, M, Sugimoto, R, Horiike, S, Tanaka, H, Konishi, M, Watanabe, S, and Adachi, Y
HEPATOLOGY 2004. 40(4): 319A-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100361
24. 44685 OI-LS-313; SCIFINDER-OI-1/5/2005
Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds
Cushion, Melanie T, Walzer, Peter D, Collins, Margaret S, Rebholz, Sandra, Vanden Eynde, Jean Jacques, Mayence, Annie, and Huang, Tien L
Antimicrobial Agents and Chemotherapy 2004. 48(11): 4209-4216
25. 44686 OI-LS-313; WOS-OI-1/2/2005
Molecular mechanism susceptibility profile of BILN-2061 to various hepatitis C virus genotypes and NS3-NS4A protease inhibitor mutation: D168A and D168V
Courcambeck, J, Perbost, R, Chabaud, P, Pepe, G, Bouzidi, M, Mabrouk, K, Sabatier, JM, and Halfon, P
HEPATOLOGY 2004. 40(4): 385A-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100515
26. 44687 OI-LS-313; WOS-OI-1/2/2005
In vitro resistance mutations against VX-950 and BILN 2061, two HCV protease inhibitor clinical candidates: Single-resistance, cross-resistance, and fitness
Lin, C, Rao, BG, Luong, YP, Fulghum, JR, Brennan, DL, Wei, YY, Frantz, JD, Lippke, J, Hsiao, HM, Ma, S, Lin, K, Maxwell, JP, Cottrell, KM, Gates, CA, Perni, RB, and Kwong, AD
HEPATOLOGY 2004. 40(4): 404A-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100554
27. 44688 OI-LS-313; WOS-OI-1/2/2005
High-throughput screening of anti-HCV drug candidates using an ELISA-based HCV replicon assay
Tan, H, Hong, J, Seiwert, S, and Blatt, LM
HEPATOLOGY 2004. 40(4): 407A-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102100560
28. 44689 OI-LS-313; SCIFINDER-OI-1/5/2005
Preparation of 2,4-diaminoquinazoline, 2-amino-4-hydroxypteridine and 2,4-diaminopyrimidine ester derivatives as dihydrofolate reductase inhibitors
Boman, Arne, Lundstedt, Torbjorn, Andersson, Per, and Seifert, Elisabeth
PATENT: WO 2004020417 ISSUE DATE: 20040311
APPLICATION: 2003 PP: 41 pp.
ASSIGNEE: (Melacure Therapeutics AB, Swed. and Pett, Christopher Phineas
29. 44690 OI-LS-313; SCIFINDER-OI-1/5/2005
Discovery of Bicyclic Thymidine Analogues as Selective and High-Affinity Inhibitors of Mycobacterium tuberculosis Thymidine Monophosphate Kinase
Vanheusden, Veerle, Munier-Lehmann, Helene, Froeyen, Matheus, Busson, Roger, Rozenski, Jef, Herdewijn, Piet, and Van Calenbergh, Serge
Journal of Medicinal Chemistry 2004. 47(25): 6187-6194
30. 44691 OI-LS-313; SCIFINDER-OI-1/5/2005
Few amino acid positions in are associated with most of the rifampin resistance in Mycobacterium tuberculosis
Cummings, Michael P and Segal, Mark R
BMC Bioinformatics 2004. 5: No pp. given
31. 44692 OI-LS-313; SCIFINDER-OI-1/5/2005
<04 Article Title>
Metaferia, Belhu B and Bewley, Carole A
<10 Journal Title> 2004.(<24 Issue ID>): <25 Page(s)>
32. 44693 OI-LS-313; SCIFINDER-OI-1/5/2005
Mycobacterium tuberculosis mutants with disabled Rv3351c (NecB) and Rv3874 genes as vaccines, for producing diagnostic antibodies and for screening tuberculosis inhibitors
King, CHarold, Jacobs, William, and Okenu, Daniel
PATENT: WO 2004067718 ISSUE DATE: 20040812
APPLICATION: 2004 PP: 144 pp.
ASSIGNEE: (Emory University, USA
33. 44694 OI-LS-313; WOS-OI-1/2/2005
Selection and characterization of hepatitis C virus replicons resistant to potent NS5B polymerase inhibitors
Lu, LJ, Mo, HM, Pilot-Matias, T, Dekhtyar, T, Ng, T, Pithawalla, R, Masse, S, Pratt, J, Donner, P, Maring, C, and Molla, A
HEPATOLOGY 2004. 40(4): 694A-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102101219
34. 44695 OI-LS-313; SCIFINDER-OI-1/5/2005
A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential
Copenhaver, Robert H, Sepulveda, Eliud, Armitige, Lisa Y, Actor, Jeffrey K, Wanger, Audrey, Norris, Steven J, Hunter, Robert L, and Jagannath, Chinnaswamy
Infection and Immunity 2004. 72(12): 7084-7095
35. 44696 OI-LS-313; SCIFINDER-OI-1/5/2005
1,3,4-Thiadiazole Derivatives. Synthesis, Structure Elucidation, and Structure-Antituberculosis Activity Relationship Investigation
Oruc, Elcin E, Rollas, Sevim, Kandemirli, Fatma, Shvets, Nathaly, and Dimoglo, Anatholy S
Journal of Medicinal Chemistry 2004. 47(27): 6760-6767
36. 44697 OI-LS-313; WOS-OI-1/2/2005
Results of a phase I single-dose escalation study of the hepatitis C protease inhibitor VX950 in healthy volunteers
Chu, HM, McNair, L, and Purdy, S
HEPATOLOGY 2004. 40(4): 735A-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224102101309
37. 44698 OI-LS-313; SCIFINDER-OI-1/5/2005
Preparation of benzimidazolyl ureas and related compounds as gyrase inhibitors for treating bacterial infections
Charifson, Paul S, Deininger, David D, Grillot, Anne-Laure, Liao, Yusheng, Ronkin, Steven M, Stamos, Dean, Perola, Emanuele, Wang, Tiansheng, Letiran, Arnaud, and Drumm, Joseph
PATENT: US 2004235886 ISSUE DATE: 20041125
APPLICATION: 2004-46742 PP: 148 pp.
ASSIGNEE: (USA)
38. 44699 OI-LS-313; SCIFINDER-OI-1/5/2005
Inhibitors of mycobacterial serine/threonine protein kinases for the treatment of mycobacterial infections
Pato, Janos, Keri, Gyorgy, Orfi, Laszlo, Waczek, Frigyes, Horvath, Zoltan, Banhegyi, Peter, Szabadkai, Istavan, Marosfalvi, Jeno, Hegymegi-Barakonyi, Balint, Szekelyhidi, Zsolt, Greff, Zoltan, Choidas, Axel, Bacher, Gerald, Missio, Andrea, and Koul, Anil
PATENT: US 2004171603 ISSUE DATE: 20040902
APPLICATION: 2003-60231 PP: 51 pp., Cont.-in-part of Appl. No. PCT/EP03-03697.
ASSIGNEE: (Hung.)
39. 44700 OI-LS-313; WOS-OI-1/2/2005
Toxicogenomics in drug discovery: from preclinical studies to clinical trials
Yang, Y, Blomme, EAG, and Waring, JF
CHEMICO-BIOLOGICAL INTERACTIONS 2004. 150(1): 71-85, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225349900007
40. 44701 OI-LS-313; WOS-OI-1/2/2005
Interaction of shikimic acid with shikimate kinase
Pereira, JH, de Oliveira, JS, Canduri, F, Dias, MVB, Palma, MS, Basso, LA, de Azevedo, WF, and Santos, DS
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2004. 325(1): 10-17, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225173400003
41. 44702 OI-LS-313; WOS-OI-1/2/2005
Cell biology of Mycobacterium tuberculosis phagosome
Vergne, I, Chua, J, Singh, SB, and Deretic, V
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY 2004. 20: 367-394, 28
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225318200014
42. 44703 OI-LS-313; WOS-OI-1/9/2005
Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates
Lenaerts, AJ, Chapman, PL, and Orme, IM
TUBERCULOSIS 2004. 84(6): 361-364, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225476500004
43. 44704 OI-LS-313; SCIFINDER-OI-1/5/2005
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation
Carter, George, Young, Lowell S, and Bermudez, Luiz E
Antimicrobial Agents and Chemotherapy 2004. 48(12): 4907-4910
44. 44705 OI-LS-313; SCIFINDER-OI-1/5/2005
Heterocyclic compounds, specifically 3,6-disubstituted 3H-furo[2,3-d]pyrimidin-2-ones and 2,6-disubstituted furo[2,3-d]pyrimidines, for use as novel nucleoside analogs and antivirals in the treatment of viral infections, particularly cytomegalovirus
McGuigan, Christopher, Balzarini, Jan, and De Clercq, Erik
PATENT: WO 2004096813 ISSUE DATE: 20041111
APPLICATION: 2004 PP: 62 pp.
ASSIGNEE: (University College Cardiff Consultants Limited, UK and Rega Foundation)
45. 44706 OI-LS-313; WOS-OI-1/9/2005
Human cytomegalovirus encodes a highly specific RANTES decoy receptor
Wang, D, Bresnahan, W, and Shenk, T
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2004. 101(47): 16642-16647, 6
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225347400048
46. 44707 OI-LS-313; SCIFINDER-OI-1/5/2005
Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines
Haraguchi, Kazuhiro, Takahashi, Haruhiko, Tanaka, Hiromichi, Hayakawa, Hiroyuki, Ashida, Noriyuki, Nitanda, Takao, and Baba, Masanori
Bioorganic & Medicinal Chemistry 2004. 12(20): 5309-5316
47. 44708 OI-LS-313; WOS-OI-1/9/2005
Screening of antibacterial and antifungal activities of ten medicinal plants from Ghana
Hoffman, BR, DelasAlas, H, Blanco, K, Wiederhold, N, Lewis, RE, and Williams, L
PHARMACEUTICAL BIOLOGY 2004. 42(1): 13-17, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225492600003
48. 44709 OI-LS-313; SCIFINDER-OI-1/5/2005
Suppression of hepatitis C virus replicon by TGF-b
Murata, Takayuki, Ohshima, Takayuki, Yamaji, Masashi, Hosaka, Masahiro, Miyanari, Yusuke, Hijikata, Makoto, and Shimotohno, Kunitada
Virology 2005. 331(2): 407-417
49. 44710 OI-LS-313; SCIFINDER-OI-1/5/2005
A strategy for obtaining near full-length HCV cDNA clones (assemblicons) by assembly PCR
Sheehy, P, Scallan, M, Kenny-Walsh, E, Shanahan, F, and Fanning, LJ
Journal of Virological Methods 2005. 123(2): 115-124
50. 44711 OI-LS-313; WOS-OI-1/9/2005
Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase
Vanheusden, V, Munier-Lehmann, H, Froeyen, M, Busson, R, Rozenski, J, Herdewijn, P, and Van, Calenbergh S
JOURNAL OF MEDICINAL CHEMISTRY 2004. 47(25): 6187-6194, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225409400010
51. 44712 OI-LS-313; WOS-OI-1/9/2005
Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitors
Sutherland, JJ and Weaver, DF
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN 2004. 18(5): 309-331, 23
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225572900002
52. 44713 OI-LS-313; WOS-OI-1/9/2005
Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability
Nassar, AEF, Kamel, AM, and Clarimont, C
DRUG DISCOVERY TODAY 2004. 9(23): 1020-1028, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225329500007
53. 44714 OI-LS-313; WOS-OI-1/9/2005
Synthesis of trehalose-based compounds and their inhibitory activities against Mycobacterium smegmatis
Wang, J, Elchert, B, Hui, Y, Takemoto, JY, Bensaci, M, Wennergren, J, Chang, H, Rai, R, and Chang, CWT
BIOORGANIC & MEDICINAL CHEMISTRY 2004. 12(24): 6397-6413, 17
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225523200007
54. 44715 OI-LS-313; WOS-OI-1/9/2005
Crystallographic and NMR studies of antiinfective tricyclic guanidine alkaloids from the sponge Monanchora unguifera
Hua, HM, Peng, JN, Fronczek, FR, Kelly, M, and Hamann, MT
BIOORGANIC & MEDICINAL CHEMISTRY 2004. 12(24): 6461-6464, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225523200012
55. 44716 OI-LS-313; WOS-OI-1/9/2005
Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues
Monga, V, Nayyar, A, Vaitilingam, B, Palde, PB, Jhamb, SS, Kaur, S, Singh, PP, and Jain, R
BIOORGANIC & MEDICINAL CHEMISTRY 2004. 12(24): 6465-6472, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225523200013
56. 44717 OI-LS-313; WOS-OI-1/9/2005
Synthesis and study of antibacterial and antifungal activities of novel 2-[[(benzoxazole/benzimidazole-2-yl)sulfanyl] acetylamino]thiazoles
Kaplancikli, ZA, Turan-Zitouni, G, Revial, G, and Guven, K
ARCHIVES OF PHARMACAL RESEARCH 2004. 27(11): 1081-1085, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225443900001